The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma

被引:19
|
作者
Sharma, Neeraj [1 ]
Smadbeck, James B. [2 ]
Abdallah, Nadine [3 ]
Zepeda-Mendoza, Cinthya [4 ]
Binder, Moritz [3 ]
Pearce, Kathryn E. [1 ]
Asmann, Yan W. [5 ]
Peterson, Jess F. [1 ,6 ]
Ketterling, Rhett P. [1 ,6 ]
Greipp, Patricia T. [1 ,6 ]
Bergsagel, P. Leif [7 ]
Rajkumar, S. Vincent [3 ]
Kumar, Shaji K. [3 ]
Baughn, Linda B. [1 ,6 ]
机构
[1] Mayo Clin, Div Lab Genet, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Computat Biol, Dept Quantitat Hlth Sci, Rochester, MN 55905 USA
[3] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA
[4] ARUP Labs, Cytogenet & Genom Microarray Lab, Salt Lake City, UT USA
[5] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Jacksonville, FL 32224 USA
[6] Mayo Clin, Div Hematopathol, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[7] Mayo Clin, Div Hematopathol, Dept Internal Med, Scottsdale, AZ USA
关键词
C-MYC; REARRANGEMENTS; LYMPHOMA; ABNORMALITIES; PROGRESSION; ACTIVATION; ONCOGENE; SURVIVAL; IMPACT;
D O I
10.1158/1078-0432.CCR-21-0005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Structural variants (SV) of the MYC gene region are common in multiple myeloma and influence disease progression. However, the prognostic significance of different MYC SVs in multiple myeloma has not been clearly established. Experimental Design: We conducted a retrospective study of multiple myeloma comparing MYC SV subtypes identified by next-generation sequencing (NGS) and FISH to MYC expression and disease survival using 140 cases from Mayo Clinic and 658 cases from the MMRF CoMMpass study. Results: MYC SVs were found in 41% of cases and were classified into nine subtypes. A correlation between the presence of a MYCSV and increased MYC expression was identified. Among the nine MYC subtypes, the non-immunoglobulin (non-Ig) insertion subtype was independently associated with improved outcomes, while the Ig insertion subtype, specifically involving the IgL gene partner, was independently associated with poorer outcomes compared with other MYC SV subtypes. Although the FISH methodology failed to detect approximately 70% of all MYC SVs, those detected by FISH were associated with elevated MYC gene expression and poor outcomes suggesting a different pathogenic role for FISH-detected MYC subtypes compared with other MYC subtypes. Conclusions: Understanding the impact of different MYC SVs on disease outcome is necessary for the reliable interpretation of MYC SVs in multiple myeloma. NGS approaches should be considered as a replacement technique for a more comprehensive evaluation of the multiple myeloma clone.
引用
收藏
页码:5430 / 5439
页数:10
相关论文
共 50 条
  • [1] Deletion of 16q identified by FISH is an independent adverse prognostic marker in multiple myeloma
    Jenner, M. W.
    Leone, P. E.
    Walker, B. A.
    Johnson, D. C.
    Chiecchio, L.
    Cabanas, E. Dachs
    Dagrada, G. P.
    Nightingale, M.
    Protheroe, R. K. M.
    Stockley, D.
    Else, M.
    Dickens, N. J.
    Ross, F. M.
    Cross, N. C. P.
    Davies, F. E.
    Morgan, G. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 1 - 1
  • [2] A Role for Germline Variants in Multiple Myeloma?
    Walker, Brian A.
    BLOOD CANCER DISCOVERY, 2024, 5 (06): : 375 - 376
  • [3] Systematic evaluation of multiple NGS platforms for structural variants detection
    Meng, Xuan
    Wang, Miao
    Luo, Mingjie
    Sun, Lei
    Yan, Qin
    Liu, Yongfeng
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (12)
  • [4] Revealing the Impact of Structural Variants in Multiple Myeloma
    Rustad, Even H.
    Yellapantula, Venkata D.
    Glodzik, Dominik
    Maclachlan, Kylee H.
    Diamond, Benjamin
    Boyle, Eileen M.
    Ashby, Cody
    Blaney, Patrick
    Gundem, Gunes
    Hultcrantz, Malin
    Leongamornlert, Daniel
    Angelopoulos, Nicos
    Agnelli, Luca
    Auclair, Daniel
    Zhang, Yanming
    Dogan, Ahmet
    Bolli, Niccolo
    Papaemmanuil, Elli
    Anderson, Kenneth C.
    Moreau, Philippe
    Avet-Loiseau, Herve
    Munshi, Nikhil C.
    Keats, Jonathan J.
    Campbell, Peter J.
    Morgan, Gareth J.
    Landgren, Ola
    Maura, Francesco
    BLOOD CANCER DISCOVERY, 2020, 1 (03): : 258 - 273
  • [5] MYC Translocations Identified By Sequencing Panel in Smoldering Multiple Myeloma Strongly Predict for Rapid Progression to Multiple Myeloma
    Keane, Niamh
    Stein, Caleb K.
    Angelov, Daniel
    Tian, Shulan
    Viswanatha, David
    Kumar, Shaji K.
    Dispenzieri, Angela
    De La Calle, Veronica Gonzalez
    Misund, Kristine
    Kyle, Robert A.
    O'Dwyer, Michael E.
    Fonseca, Rafael A.
    BLOOD, 2017, 130
  • [6] Prognostic Significance of the FISH Panel for Patients with Multiple Myeloma
    Rothman, Rachel
    Voskoboinik, Nadia
    Herishanu, Yair
    Orr-Urtreger, Avi
    Naparstek, Elizabeth
    Trestman, Svetlana
    BLOOD, 2012, 120 (21)
  • [7] Classification of multiple myeloma into prognostic groups based on karyotype and FISH
    Aviv, H. A.
    Maxwell, I.
    Wang, J.
    Vassallo, K.
    Ninan, A.
    Creese, C.
    Ang, D.
    CYTOGENETIC AND GENOME RESEARCH, 2008, 121 (01)
  • [8] ANALYSIS OF PROGNOSTIC IMPACT OF MOLECULAR RESPONSE ASSESSED BY 2 METHODS OF NGS IN MULTIPLE MYELOMA
    Fernandez Rafael, Alonso
    Beatriz, Sanchez-Vega
    Santiago, Barrio
    Isabel, Cuenca
    Yanira, Ruiz-Heredia
    Carlos, Marin
    Inmaculada, Rapado
    Cristina, Jimenez
    Xabier, Agirre
    Jose, Cervera
    Rosa, Ayala
    Teresa, Cedena
    Bruno, Paiva
    Maria Victoria, Mateos
    Laura, Rosinol
    Joan, Blade
    Miguel Jesus, San
    Juan Jose, Lahuerta
    Ramon, Garcia-Sanz
    Joaquin, Martinez-Lopez
    HAEMATOLOGICA, 2016, 101 : 23 - 24
  • [9] Prognostic role of circulating exosomal miRNAs in multiple myeloma
    Manier, Salomon
    Liu, Chia-Jen
    Avet-Loiseau, Herve
    Park, Jihye
    Shi, Jiantao
    Campigotto, Federico
    Salem, Karma Z.
    Huynh, Daisy
    Glavey, Siobhan V.
    Rivotto, Bradley
    Sacco, Antonio
    Roccaro, Aldo M.
    Bouyssou, Juliette
    Minvielle, Stephane
    Moreau, Philippe
    Facon, Thierry
    Leleu, Xavier
    Weller, Edie
    Trippa, Lorenzo
    Ghobrial, Irene M.
    BLOOD, 2017, 129 (17) : 2429 - 2436
  • [10] Prognostic role of miRNome-profiling in multiple myeloma
    Seckinger, A.
    Meissner, T.
    Benes, V
    Schmidt, S.
    Blake, J.
    Zimmermann, J.
    Goldschmidt, H.
    Klein, B.
    Hose, D.
    ONKOLOGIE, 2011, 34 : 18 - 19